Verrica Pharmaceuticals Inc. (VRCA) Form 8-K — Jun 9, 2026
Verrica Pharmaceuticals stockholders approved the Amended and Restated 2018 Equity Incentive Plan and elected two directors at the 2026 Annual Meeting held on June 5, 2026. The equity plan reserves 4 million shares of common stock and includes an automatic annual increase of 5% for ten years to facilitate employee and director incentives.
Key figures
- Shares Outstanding
- 17178786
- Iso Limit
- 12000000
- Plan Share Reserve
- 4000000
- Plan Annual Increase Years
- 10
- Plan Annual Increase Percent
- 5.0%
- Non Employee Director Comp Limit
- 600000
Price after filing
1 day: -6.0%7 days: -2.0%30 days: +8.2%
Close on the filing date to close N calendar days later (from $6.12). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.